https://www.biopharminternational.com/view/reithera-expands-viral-vector-production-capabilities-with-opening-of-new-manufacturing-facility
0
0
11/14/22 at 7:57pm
Organization
Biopharminternational.com
34 words
0
Comments
The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.
You are the first to view
Create an account
or login to join the discussion